Use of a Mixed Agent Prophylactic Laxative Regimen in the Medical Intensive Care Unit Leads to Reduced Length of

Christopher J Costa1, Rachael Hagen1, Raymond Foley2

  • 1Department of Medicine, University of Connecticut Health Center, Farmington, USA.

Insights

Implementing proactive laxative use and improved bowel movement charting in the Medical Intensive Care Unit (MICU) reduced patient length of stay and time to first bowel movement. This initiative aimed to prevent constipation and improve patient outcomes in critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Gastroenterology
  • Healthcare Process Improvement

Background:

  • Impaired gastrointestinal (GI) tract function, particularly reduced bowel movements, is common in Medical Intensive Care Units (MICUs).
  • This dysfunction is linked to increased length of stay, morbidity, and mortality, often exacerbated by delayed enteral feeding.
  • Current management is often reactive, failing to proactively address constipation.

Purpose of the Study:

  • To enhance the visibility of bowel movement charting within the electronic medical record.
  • To transition from a reactive to a proactive regimen for administering laxatives to prevent MICU-associated constipation.
  • To evaluate the impact of these process changes on laxative utilization, length of stay, and time to first bowel movement.

Main Methods:

  • A process implementation project was conducted at a single academic center.
  • Scheduled prophylactic laxatives (polyethylene glycol and sennoside-docusate) were integrated into the MICU admission orderset.
  • Bowel movement charting was relocated to a more accessible flowsheet in the electronic medical record.
  • Six months of pre- and post-intervention data were analyzed for patient demographics, diagnoses, SOFA scores, laxative use, and time to first bowel movement.

Main Results:

  • Prophylactic laxative utilization significantly increased post-intervention (p < .001), largely due to the orderset integration.
  • MICU length of stay decreased by an average of 21 hours (p = .006).
  • Median time to first bowel movement decreased by 4 hours (p = .026).
  • No significant change was observed in the incidence of impaired transit (defined as >72 hours without a bowel movement).

Conclusions:

  • The implementation of a proactive, mixed-agent prophylactic laxative regimen and improved charting visibility is a promising first step in managing constipation in the MICU.
  • These changes were associated with reduced length of stay and faster return of bowel function.
  • Further investigation into optimizing prophylactic laxative strategies is warranted.

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...